Knopp
Electronics · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1307 66th St, Emeryville, California, 94...Phone Number
(510) 653-1661Website
www.knoppinc.comRevenue
<$5 MillionIndustry
About Knopp
Knopp Org Chart
Is Knopp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Knopp, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Knopp is spiking on competitors!
Product Launch: Get notified when Knopp launches new products
Congratulate Masked Content for being promoted to Masked Content at Knopp
Earning: See what the market has to say on Knopp recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Knopp has new funding data
Check if Knopp has recently received funding, and reach out quickly before it becomes old news!
Click to see if Knopp had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Knopp
Find 3 more new buyers
Compare Similar Companies to Knopp
Compare insights from companies similar to Knopp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Knopp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Knopp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Knopp.
Knopp Tech Stack
A closer look at the technologies used by Knopp
Knopp News & Media
Le programme Knopp Biosciences de lutte contre la douleur, financé par les Instituts américains de la santé publique (NIH), entame sa troisième année de l'initiative HEAL pour la découverte de thérapies non opiacés contre la douleur chronique
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC a annoncé aujourd’hui avoir obtenu une troisième année de financement de recherche de la part des Instituts américains de la santé publique (National Institutes of Health, NIH), pour faire progresser le développement de ses nouvelles thérapies non opiacées destinées à traiter les douleurs chroniques. Le projet est financé par l’Initiative des NIH visant à mettre un terme aux addictions à long terme (la NIH Helping to End Addiction Long-term (HERiassunto: Il programma per la gestione del dolore finanziato dall’NIH di Knopp Biosciences si aggiudica un terzo anno di finanziamento da parte dell’iniziativa HEAL per la scoperta di opzioni terapeutiche non oppioidi per il trattamento del dolore cronico
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC ha annunciato oggi di essersi aggiudicata un terzo anno di finanziamento delle proprie attività di ricerca da parte dei National Institutes of Health (NIH) per accelerare lo sviluppo di nuove terapie non oppioidi per il trattamento del dolore cronico. Il progetto è finanziato dall’iniziativa denominata “NIH Helping to End Addiction Long-term Initiative” (iniziativa NIH HEAL), che è finalizzata a migliorare le terapie per il trattamento del doloKnopp Biosciences annonce de premiers résultats positifs de l'essai EXHALE de Phase 2 sur le dexpramipexole oral dans le traitement de l’asthme éosinophilique modéré à sévère
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC a annoncé aujourd'hui les premiers résultats positifs d’un essai de Phase 2 de détermination de dose, portant sur le dexpramipexole oral administré à des patients atteints d'asthme éosinophilique modéré à sévère. L'étude EXHALE a atteint son critère d’évaluation principal, le dexpramipexole ayant démontré une réduction statistiquement significative, dépendante de la dose, de la numération absolue des éosinophiles (NAE) par rapport au niveau deLe programme Knopp Biosciences pour la lutte contre la douleur, financé par les Instituts nationaux de la santé publique (NIH), entame sa seconde année du programme HEAL pour la découverte de traitements non opiacés de la douleur chronique
PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC a annoncé aujourd'hui entrer dans la deuxième année de recherche financée par les Instituts nationaux de la santé (NIH) afin d'utiliser sa plateforme Kv7 pour découvrir et développer des thérapies non opiacées pour le traitement de la douleur chronique. Le projet est financé par le programme des NIH intitulé "Helping to End Addiction Long-term" (le NIH HEAL Initiative), qui vise à améliorer les traitements de la douleur chronique, à réduire les
Top Electronics Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Knopp
Knopp Inc. is a design and manufacturing company located in Emeryville, California, USA (alongside beautiful San Francisco Bay). We have been in business since 1928 -- if you're counting, that makes 20 16 our 88th year. Our primary products are transformer test equipment, precision voltage and current transformers, and electrical instruments. Our c... Read More